The imbalance between regulatory memory B cells reveals possible pathogenesis involvement in pediatric immune thrombocytopenia

References

• Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386–2393. doi: 10.1182/blood-2008-07-162503
   PubMed Web of Science ®Google Scholar
• Azizi G, Abolhassani H, Asgardoon MH, et al. Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management. Expert Rev Clin Immunol. 2017;13:101–115. doi: 10.1080/1744666X.2016.1224664
   PubMed Web of Science ®Google Scholar
• Sanchez-Ramon S, Radigan L, Yu JE, et al. Memory B cells in common variable immunodeficiency: clinical associations and sex differences. Clin Immunol. 2008;128:314–321. doi: 10.1016/j.clim.2008.02.013
   PubMed Web of Science ®Google Scholar
• Arumugakani G, Wood PM, Carter CR. Frequency of Treg cells is reduced in CVID patients with autoimmunity and splenomegaly and is associated with expanded CD21lo B lymphocytes. J Clin Immunol. 2010;30:292–300. doi: 10.1007/s10875-009-9351-3
   PubMed Web of Science ®Google Scholar
• Giordano P, Cascioli S, Lassandro G, et al. B-cell hyperfunction in children with immune thrombocytopenic purpura persists after splenectomy. Pediatr Res. 2016;79(2):262–270. doi: 10.1038/pr.2015.211
   PubMed Web of Science ®Google Scholar
• Rosser EC, Mauri C. Regulatory B cells: origin, phenotype, and function. Immunity. 2015;42(4):607–612. doi: 10.1016/j.immuni.2015.04.005
   PubMed Web of Science ®Google Scholar
• Athanasios M, Theodora S, Areti V, et al. Breg cells are numerically decreased and functionally impaired in patients with systemic sclerosis. Arthritis Rheumatol. 2016;68(2):494–504. doi: 10.1002/art.39437
   PubMed Web of Science ®Google Scholar
• Kristensen B, Hegedus L, Lundy SK, et al. Characterization of regulatory B cells in Graves’ disease and Hashimoto’s thyroiditis. PLoS One. 2015;10(5):e0127949. doi: 10.1371/journal.pone.0127949
   PubMed Web of Science ®Google Scholar
• Blair PA, Norena LY, Flores-Borja F, et al. CD19 + CD24hiCD38hi b cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity. 2010;32(1):129–140. doi: 10.1016/j.immuni.2009.11.009
   PubMed Web of Science ®Google Scholar
• Li X, Zhong H, Bao W, et al. Defective regulatory B-cell compartment in patient with immune thrombocytopenia. Blood. 2012;120:3318–3325. doi: 10.1182/blood-2012-05-432575
   PubMed Web of Science ®Google Scholar
• Duddy M, Niino M, Adatia F, et al. Distinct effector cytokine profiles of memory and naïve human B cell subsets and implication in multiple sclerosis. J Immunol. 2007;178(10):6092–6099. doi: 10.4049/jimmunol.178.10.6092
   PubMed Web of Science ®Google Scholar
• Kim SH, Kim W, Li XF, et al. Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years. Arch. Neurol. 2011;68(11):1412–1420. doi: 10.1001/archneurol.2011.154
   PubMedGoogle Scholar
• Klein U, Rajewsky K, Kuppers R. Human immunoglobulin IgM + IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as ageneral marker for somatically mutated (memory) B cells. J Exp Med. 1998;188:1679–1689. doi: 10.1084/jem.188.9.1679
   PubMed Web of Science ®Google Scholar
• Korganow AS, Knapp AM, Nehme-Schuster H, et al. Peripheral B cell abnormalities in patients with systemic lupus erythematous in quiescent phase: decreased memory B cells and membrane CDl9 expression. J Autoimmun. 2010;34(4):426–434. doi: 10.1016/j.jaut.2009.11.002
   PubMed Web of Science ®Google Scholar
• Souto-Carneiro MM, Mahadevan V, Takada K, et al. Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor. Arthritis Res Ther. 2009;11(3):R84. doi: 10.1186/ar2718
   PubMed Web of Science ®Google Scholar
• Lyu M, Hao Y, Li Y, et al. Upregulation of CD72 expression on CD19 + CD27+ memory B cells by CD40L in primary immune thrombocytopenia. Br J Haematol. 2017;178(2):308–318. doi: 10.1111/bjh.14671
   PubMed Web of Science ®Google Scholar
• Mauri C, Menon M. The expanding family of regulatory B cells. Int Immunol. 2015;27(10):479–486. doi: 10.1093/intimm/dxv038
   PubMed Web of Science ®Google Scholar
• Sylvain A, Matthieu M, Maxime S, et al. Pathogenesis of immune thrombocytopenia. Autoimmun Rev. 2017;16:620–632. doi: 10.1016/j.autrev.2017.04.012
   PubMed Web of Science ®Google Scholar
• Mauri C, Bosma A. Immune regulatory function of B cells. Ann Rev Immunol. 2012;30:221–241. doi: 10.1146/annurev-immunol-020711-074934
   PubMed Web of Science ®Google Scholar
• Carter NA, Vasconcellos R, Rosser EC, et al. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol. 2011;186(10):5569–5579. doi: 10.4049/jimmunol.1100284
   PubMed Web of Science ®Google Scholar
• Qianzi Z, Jung LK. Frequency of CD19 + CD24hiCD38hiregulatory B cell is decreased in peripheral blood and synovial fluid of patients with juvenile idiopathic arthritis: a preliminary study. Pediatr Rheumatol. 2018;16(44):1–9.
   PubMed Web of Science ®Google Scholar
• Palomares O, Akdis M, Martín-Fontecha M, et al. Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells. Immunol Rev. 2017;278:219–236. doi: 10.1111/imr.12555
   PubMed Web of Science ®Google Scholar
• Asmaa M, Sanaa S, Ahmed E, et al. Regulatory and memory B lymphocytes in children with newly diagnosed immune thrombocytopenia. J Hematol. 2017;6(4):81–86. doi: 10.14740/jh336w
   PubMedGoogle Scholar
• Masson A, Bouaziz JD, Le Buanec H, et al. CD24hiCD27+ and plasma blast-like regulatory B cells in human chronic graft-versus-host disease. Blood. 2015;125(11):1830–1839. doi: 10.1182/blood-2014-09-599159
   PubMed Web of Science ®Google Scholar
• Jin L, Weiqian C, Lihuan Y. Peripheral CD24hi CD27+ CD19+ B cells subset as a potential biomarker in naive systemic lupus erythematosus. Int J Rheum Dis. 2013;16:698–708. doi: 10.1111/1756-185X.12229
   PubMed Web of Science ®Google Scholar
• Dorner T. Crossroads of B cell activation in autoimmunity: rationale of targeting B cells. J Rheumatol Suppl. 2006;77:3–11.
   PubMedGoogle Scholar
• Roll P, Palanichamy A, Kneitz, C, et al. Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis. Arthritis Rheum. 2006;54(8):2377–2386. doi: 10.1002/art.22019
   PubMed Web of Science ®Google Scholar
• Imbach P, Barandun S, d'Apuzzo V, et al. High-dose intravenous gamma globulin for idiopathic thrombocytopenic purpura in childhood. Lancet. 1981;1:1228–1231. doi: 10.1016/S0140-6736(81)92400-4
   PubMed Web of Science ®Google Scholar
• Ballow M. Mechanisms of action of intravenous immune serum globulin therapy. Pediatr Infect Dis J. 1994;13:806–811. doi: 10.1097/00006454-199409000-00012
   PubMed Web of Science ®Google Scholar
• Labarque V, Van Geet C. Clinical practice: immune thrombocytopenia in paediatrics. Eur J Pediatr. 2014;173:163–172. doi: 10.1007/s00431-013-2254-6
   PubMed Web of Science ®Google Scholar
• Kessel A, Ammuri H, Peri R, et al. Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function. J Immunol. 2007;179:5571–5575. doi: 10.4049/jimmunol.179.8.5571
   PubMed Web of Science ®Google Scholar
• Hori A, Fujimura T, Kawamoto S. Anti-inflammatory intravenous immunoglobulin (IVIg) suppresses homeostatic proliferation of B cells. Cytotechnology. 2018;70(3):921–927. doi: 10.1007/s10616-017-0176-2
   PubMed Web of Science ®Google Scholar
• Gruver-Yates AL, Quinn MA, Cidlowski JA. Analysis of glucocorticoid receptors and their apoptotic response to dexamethasone in male murine B cells during development. Endocrinology. 2014;155(2):463–474. doi: 10.1210/en.2013-1473
   PubMed Web of Science ®Google Scholar
• Kovacs WJ. To B or not to B? Glucocorticoid impact on B lymphocyte fate and function. Endocrinology. 2014;155(2):339–342. doi: 10.1210/en.2013-2085
   PubMed Web of Science ®Google Scholar